Toward defining schizophrenia as a more useful clinical concept

Current Psychiatry Reports

Volumn 10, Issue 4, 2008, Pages 344-351

  Fiedorowicz, Jess G ^b   Epping, Eric A ^b   Flaum, Michael ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; GENETIC ANALYSIS; HALLUCINATION; HUMAN; NOMENCLATURE; PHENOTYPE; PSYCHOSIS; PUBLICATION; REVIEW; RISK FACTOR; SCHIZOPHRENIA;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; NERVE TISSUE PROTEINS; PHENOTYPE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEINS;

EID: 48749126103     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0055-9     Document Type: Review

References (52)

1. Jansson LB, Parnas J: Competing definitions of schizophrenia: what can be learned from polydiagnostic studies? Schizophr Bull 2007, 33:1178-1200.
2. Jakobsen KD, Frederiksen JN, Parnas J, Werge T: Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses. Psychopathology 2006, 39:269-276.
3. Schimmelmann BG, Conus P, Edwards J, et al.: Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005, 66:1239-1246.
4. Averill PM, Reas DL, Shack A, et al.: Is schizoaffective disorder a stable diagnostic category: a retrospective examination. Psychiatr Q 2004, 75:215-227.
5. Modestin J, Huber A, Satirli E, et al.: Long-term course of schizophrenic illness: Bleuler's study reconsidered. Am J Psychiatry 2003, 160:2202-2208.
6. Rossler W, Riecher-Rossler A, Angst J, et al.: Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res 2007, 92:1-14.
7. Jaspers K: General Psychopathology. Baltimore, MD: The Johns Hopkins University Press; 1997.
8. Delespaul P, van Os J: Jaspers was right after all-delusions are distinct from normal beliefs. Against. BrJ Psychiatry 2003, 183:286.
9. Kendler KS, Glazer WM, Morgenstern H: Dimensions of delusional experience. Am J Psychiatry 1983, 140:466-469.
10. Kroll JL: New directions in the conceptualization of psychotic disorders. Curr Opin Psychiatry 2007, 20:573-577.
11. Peralta V, Cuesta MJ: The nosology of psychotic disorders: a comparison among competing classification systems. Schizophr Bull 2003, 29:413-425.
12. Dikeos DG, Wickham H, McDonald C, et al.: Distribution of symptom dimensions across Kraepelinian divisions. Br J Psychiatry 2006, 189:346-353.
13. Allardyce J, Suppes T, Van Os J: Dimensions and the psychosis phenotype. Int J Methods Psychiatr Res 2007, 16(Suppl 1):S34-S40.
14. Marengo J, Harrow M, Herbener ES, Sands J: A prospective longitudinal 10-year study of schizophrenia's three major factors and depression. Psychiatry Res 2000, 97:61-77.
15. Wickham H, Walsh C, Asherson P, et al.: Familiality of symptom dimensions in schizophrenia. Schizophr Res 2001, 47:223-232.
16. Lindenmayef JP, Brown E, Baker RW, et al.: An excitement subscale of the Positive and Negative Syndrome Scale. Schizophr Res 2004, 68:331-337.
17. Murray V, McKee I, Miller PM, et al.: Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses. Psychol Med 2005, 35:499-51O.
18. Kempf L, Hussain N, Potash JB: Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. Int Rev Psychiatry 2005, 17:9-19.
19. Cheniaux E, Landeira-Fernandez J, Lessa Telles L, et al.: Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J Affect Disord 2008, 106:209-217.
20. Keefe RS, Fenton WS: How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull 2007, 33:912-920.
21. Klingberg S, Wittorf A, Wiedemann G: Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions? Eur Arch Psychiatry Clin Neurosci 2006, 256:532-540.
22. Andreasen NC: DSM and the death of phenomenology in America: an example of unintended consequences. Schizophr Bull 2007, 33:108-112.
23. Helmes E, Landmark J: Subtypes of schizophrenia: a cluster analytic approach. Can J Psychiatry 2003, 48:702-708.
24. Johannesen JK, Kieffaber PD, O'Donnell BF, et al.: Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophr Res 2005, 78:269-284.
25. Segal M, Avital A, Berstein S, et al.: Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:378-382.
26. Carpenter WT Jr, Heinrichs DW, Wagman AM: Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988, 145:578-583.
27. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr: A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 2001, 58:165-171.
28. Cohen AS, Saperstein AM, Gold JM, et al.: Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull 2007, 33:1201-1212.
29. Flaum M, Andreasen N: The reliability of distinguishing primary versus secondary negative symptoms. Compr Psychiatry 1995, 36:421-427.
30. Gottesman II, Shields J: Schizophrenia and Genetics: A Twin Study Vantage Point. New York: Academic Press; 1972.
31. Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
32. Braff DL, Freedman R, Schork NJ, Gottesman II: Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 2007, 33:21-32.
33. Keshavan MS, Prasad KM, Pearlson G: Are brain structural abnormalities useful as endophenotypes in schizophrenia? Int Rev Psychiatry 2007, 19:397-406.
34. Greenwood TA, Braff DL, Light GA, et al.: Initial heritability analyses of endophenotypic measures for schizophrenia. the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 2007, 64:1242-1250.
35. Leonard S, Freedman R: Genetics of chromosome 15q13q14 in schizophrenia. Biol Psychiatry 2006, 60:115-122.
36. Olincy A, Harris JG, Johnson LL, et al.: Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 2006, 63:630-638.
37. Watanabe A, Toyota T, Owada Y, et al.: Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol 2007, 5:e297.
38. Chubb JE, Bradshaw NJ, Soares DC, et al.: The DISC locus in psychiatric illness. Mol Psychiatry 2008, 13:36-64.
39. Ho BC, Andreasen NC, Dawson JD, Wassink TH: Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007, 164:1890-1899.
40. Ho BC, Milev P, O'Leary DS, et al.: Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006, 63:731-740.
41. Simonsen C, Sunder K, Vaskinn A, et al.: Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disord 2008, 10:245-255.
42. Turetsky BI, Calkins ME, Light GA, et al.: Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 2007, 33:69-94.
43. Kathmann N, Hochrein A, Uwer R, Bondy B: Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. Am J Psychiatry 2003, 160:696-702.
44. Craddock N, O'Donovan MC, Owen MJ: Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006, 32:9-16.
45. Martin LF, Hall MH, Ross RG, et al.: Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatry 2007, 164:1900-1906.
46. McGorry PD, Purcell R, Hickie IB, et al.: Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust 2007, 187:S40-S42.
47. Cougnard A, Marcelis M, Myin-Germeys I, et al.: Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med 2007, 37:513-527.
48. Levin T: Schizophrenia should be renamed to help educate patients and the public. Int J Soc Psychiatry 2006, 52:324-331.
49. Andreasen NC, Paradiso S, O'Leary DS: "Cognitive dysmetria:as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 1998, 24:203-218.
50. Sato M: Renaming schizophrenia: a Japanese perspective. World Psychiatry 2006, 5:53-55.
51. Adityanjee, Aderibigbe YA, Theodoridis D, Vieweg VR: Dementia praecox to schizophrenia: the first 100 years. Psychiatry Clin Neurosci 1999, 53:437-448.
52. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders IV-TR. Washington, DC: American Psychiatric Association; 2000.